Qiming U.S. Healthcare Fund Ii, L.P. Jasper Therapeutics, Inc. (JSPR) insider trading activity

Qiming U.S. Healthcare Fund Ii, L.P. is > 10% Shareholder of Jasper Therapeutics, Inc.. Currently has a direct ownership of 8.52 Million shares of JSPR, which is worth approximately $189 Million. The most recent transaction as insider was on Jan 27, 2023, when has been sold 2,666,666 shares (Voting Common Stock) at a price of $1.5 per share, resulting in proceeds of $3,999,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.52M

0% 3M change

0% 12M change

Total Value Held $189 Million

Qiming U.S. Healthcare Fund II, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 27 2023	BUY Open market or private purchase	$3,999,999 $1.5 p/Share	2,666,666 Added 23.84%	8,519,648 Voting Common Stock

Also insider at

ELEV

Elevation Oncology, Inc. Healthcare

> 10% Shareholder

ICVX

Icosavax, Inc. Healthcare

QUH